CLINICAL TRIALS PROFILE FOR AMOXIL
✉ Email this page to a colleague
All Clinical Trials for AMOXIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00377403 ↗ | Treatment of Acute Sinusitis | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 | 2006-10-01 | This study will compare the symptom relief provided by 5 cold medicines versus the symptom relief provided by the same 5 cold medicines plus the antibiotic, amoxicillin, in people who have sinus infections. Treatment with amoxicillin may be more effective than treatment with cold medicines alone. Two hundred adult volunteers, aged 18 to 70 years old, with sinus infections will participate in this study for 28 days. Volunteers will receive a 10-day course of either amoxicillin or placebo (substance containing no medication). In addition, all volunteers will receive pain medication, a chest decongestant, nasal decongestants, and cough medicine as needed. Volunteers will be interviewed by telephone on days 0, 3, 7, 10, and 28 following the start of treatment. The study will look at quality of life factors such as change in functional status (ability to perform daily activities) and symptoms, recurrence of the infection, satisfaction with care, and the direct costs of treatment. |
| NCT00377403 ↗ | Treatment of Acute Sinusitis | Completed | Washington University School of Medicine | Phase 4 | 2006-10-01 | This study will compare the symptom relief provided by 5 cold medicines versus the symptom relief provided by the same 5 cold medicines plus the antibiotic, amoxicillin, in people who have sinus infections. Treatment with amoxicillin may be more effective than treatment with cold medicines alone. Two hundred adult volunteers, aged 18 to 70 years old, with sinus infections will participate in this study for 28 days. Volunteers will receive a 10-day course of either amoxicillin or placebo (substance containing no medication). In addition, all volunteers will receive pain medication, a chest decongestant, nasal decongestants, and cough medicine as needed. Volunteers will be interviewed by telephone on days 0, 3, 7, 10, and 28 following the start of treatment. The study will look at quality of life factors such as change in functional status (ability to perform daily activities) and symptoms, recurrence of the infection, satisfaction with care, and the direct costs of treatment. |
| NCT00778050 ↗ | Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2002-10-01 | This study compared the relative bioavailability (rate and extent of absorption) of amoxicillin tablets for oral suspension 600 mg by Ranbaxy Laboratories Limited with that of Amoxil ® for oral suspension 400 mg/ 5 mL by SmithKline Beecham Pharmaceuticals following single oral dose (600 mg) in healthy, adult, subjects under fasting conditions using a randomized two-way crossover design. |
| NCT01431989 ↗ | Amoxicillin Bioequivalence Study Brazil - Fast | Completed | GlaxoSmithKline | Phase 1 | 2011-05-27 | This study is prospective, open-label, randomized, crossover, single dose, with 02 treatments, 02 sequences and 02 periods. The volunteers received, in each period, the reference or the test formulation, according to the randomization list, under fasting conditions, in order to evaluate if the reference and test formulations are bioequivalent. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMOXIL
Condition Name
| Condition Name for AMOXIL | |
| Intervention | Trials |
| Community-acquired Pneumonia | 3 |
| Helicobacter Pylori Infection | 3 |
| Treatment of H. Pylori Infection | 1 |
| Eradication of H.Pylori by Adding Lactoferrin to Slandered or Sequential Therapy | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for AMOXIL
Trials by Country
Clinical Trial Progress for AMOXIL
Clinical Trial Phase
Clinical Trial Sponsors for AMOXIL
Sponsor Name
